Margin Test Ahead: Defence Orders Steady, Cost Inflation in Focus
With a ₹2,290 cr order book and 20% revenue growth guidance, MIDHANI enters Q1 FY27 on bullish footing. The Street debates near-term margin pressure against medium-term capex-enabled recovery.
MIDHANI reports Q1 FY27 results on August 12, with a robust order book (₹2,290 cr) and 20% full-year revenue guidance anchoring expectations. Yet the Street's near-term debate centers on margins: Q4 FY26 saw EBITDA margins compress 222 bps to 19.8% due to raw material cost inflation and a less favorable product mix. The key question for Q1 is whether cost pressures have stabilized—and whether the company can steer toward higher-margin special alloys ahead of its ₹1,000 cr capex ramp.
What to Expect
~₹300–350 Cr
In line with 20% FY27 growth guidance; compares to ~₹275 Cr in Q1 FY26
~19–21%
Near-term pressure likely; Q4 FY26 was 19.8%; relief depends on product mix and commodity costs
₹2,290 Cr
Plus ₹1,100 Cr pipeline; provides multi-year revenue visibility and confidence in defence demand
~65–70%
Core driver; indigenization tailwinds (jet engines, missiles, aerospace alloys) support volume growth
A strong Q1 would show revenue in the upper half of ₹300–350 Cr with EBITDA margins stable or rising on favorable mix (higher-value superalloys, titanium specialties). PAT growth should exceed 15% YoY. A weak Q1 would print below ₹300 Cr revenue or margins sub-19%, signaling prolonged cost headwinds or order execution delays. The Street looks for capex progress updates (automation, titanium, single-crystal blade materials).
On Track?
MIDHANI has delivered steady order inflows despite defence capex cycles, and FY26 revenues rose 12.5% (to ~₹1,209 Cr) with PAT up 19%. However, margins lagged: EBITDA growth (10.7%) trailed revenue, indicating cost pressures are real. The company's FY27 guidance (20% revenue growth) is ambitious; if realised, it would mark an acceleration. The capex ramp (₹1,000 Cr over 3 years) is the vehicle for margin recovery—but payoff is medium-term (FY27–FY28). Q1 will be watched for evidence that the company is managing input costs and shifting product mix upward.
What the Street Says
Since Last Quarter
Aug 1: GM (Production) Shri Anand Kumar Kaluvala retired. Routine transition in a PSU; no operational impact flagged. Jun 5: New Government Nominee Director appointed (Shri Prakash Rajpurohit replaces Shri Amit Satija). Board composition change in line with government shareholding rights. May 29: FY26 final results approved; ₹1.25 dividend per share recommended (12.5% payout). Strong capital return posture. May 27: Regulatory fine (₹4.95L each, BSE and NSE) for Q4 FY26 board composition non-compliance under SEBI LODR. Non-material; company has not yet paid. Jun 25: Trading window closed for Q1 FY27 results (standard SEBI compliance). Summary: Routine governance and compliance events; no material business risk or opportunity flagged in recent filings.
What to Watch on Result Day
1 · EBITDA Margin Trajectory
Is Q1 margin at or above Q4 FY26's 19.8%? Any commentary on cost inflation normalization or product mix improvement? This is the linchpin for Street conviction on 200 bps capex-driven recovery by year-end.
2 · New Defence Orders & Pipeline
Any fresh large orders announced? Updates on ₹1,100 Cr pipeline conversion? Defence indigenization orders (e.g., new aero-engine, missile alloys) would reinforce medium-term growth story and offset near-term margin skepticism.
3 · Capex Execution & Titanium Scale
Progress on ₹1,000 Cr automation / titanium expansion / single-crystal blade development? Management commentary on timeline to margin recovery will shape FY27 guidance credibility and Street re-rating.
MIDHANI enters Q1 FY27 with tailwinds (robust defence order book, indigenous capex, government support) but headwinds (cost inflation, margin compression). The Street remains bullish on 12–18 month returns (target ₹464–487), yet consensus is split on near-term margin pressure. August 12 results will either confirm that cost normalization is underway—resetting margin recovery expectations upward—or extend the cautious posture through Q2. Watch the three items above closely; weak margins paired with slowing capex progress could trigger downgrades, while stable-to-improving margins and brisk order inflows would re-accelerate bullish momentum into the festive season defence sector ramp.
Informational and educational content only. Not investment advice.